{"title":"Agent-Based Model of Cell Signaling in Cancer","authors":"Y. Derbal","doi":"10.1109/CCECE47787.2020.9255675","DOIUrl":null,"url":null,"abstract":"Cancer is a genetic disease whose growth and proliferation is driven by the dysregulation of cell signaling and an aberrant metabolism. A better understanding of signaling dysregulation dynamics in cancer cells would inform the development of more effective therapies. In this respect, an agent-based model of cellular pathways is developed to study the dynamics of the cell signaling circuit in closed loop with cell metabolism. The model focuses on signaling pathways that involve frequently altered cancer genes. This would support explorations of therapeutic strategies aimed at derailing cancer proliferation through disruptions of major oncogenic pathways.","PeriodicalId":296506,"journal":{"name":"2020 IEEE Canadian Conference on Electrical and Computer Engineering (CCECE)","volume":"102 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2020-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2020 IEEE Canadian Conference on Electrical and Computer Engineering (CCECE)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/CCECE47787.2020.9255675","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Cancer is a genetic disease whose growth and proliferation is driven by the dysregulation of cell signaling and an aberrant metabolism. A better understanding of signaling dysregulation dynamics in cancer cells would inform the development of more effective therapies. In this respect, an agent-based model of cellular pathways is developed to study the dynamics of the cell signaling circuit in closed loop with cell metabolism. The model focuses on signaling pathways that involve frequently altered cancer genes. This would support explorations of therapeutic strategies aimed at derailing cancer proliferation through disruptions of major oncogenic pathways.